These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8106165)

  • 21. The preventative effects of vasodilating beta-blockers in cardiovascular disease.
    Raftery EB
    Eur Heart J; 1996 Apr; 17 Suppl B():30-8. PubMed ID: 8733069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol. Results of a randomised study].
    Latini R
    Ital Heart J Suppl; 2001 Jun; 2(6):692-3. PubMed ID: 11460849
    [No Abstract]   [Full Text] [Related]  

  • 23. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol in ischaemic heart disease.
    Prichard BN
    Cardiology; 1993; 82 Suppl 3():34-9. PubMed ID: 8106163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carvedilol in the treatment of chronic heart failure.
    Moe G
    Expert Opin Pharmacother; 2001 May; 2(5):831-43. PubMed ID: 11336626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol.
    Giardini A; Formigari R; Bronzetti G; Prandstraller D; Donti A; Bonvicini M; Picchio FM
    Cardiol Young; 2003 Aug; 13(4):333-6. PubMed ID: 14694952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group.
    Krum H; Shusterman N; MacMahon S; Sharpe N
    J Card Fail; 1998 Dec; 4(4):281-8. PubMed ID: 9924849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
    Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker.
    Wright DJ; Cooke GA; Tan LB
    Heart; 1997 Jun; 77(6):581-2. PubMed ID: 9227309
    [No Abstract]   [Full Text] [Related]  

  • 34. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
    [No Abstract]   [Full Text] [Related]  

  • 36. Carvedilol.
    Cohn LJ
    N Engl J Med; 1999 May; 340(18):1443-4. PubMed ID: 10328713
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
    Takeda Y; Fukutomi T; Suzuki S; Yamamoto K; Ogata M; Kondo H; Sugiura M; Shigeyama J; Itoh M
    Am J Cardiol; 2004 Aug; 94(4):448-53. PubMed ID: 15325927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of carvedilol in pediatric heart failure.
    Christensen AH; Fatkin D
    Future Cardiol; 2013 Jul; 9(4):475-8. PubMed ID: 23834688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin-induced cardiomyopathy treated with carvedilol.
    Fazio S; Palmieri EA; Ferravante B; Bonè F; Biondi B; Saccà L
    Clin Cardiol; 1998 Oct; 21(10):777-9. PubMed ID: 9789703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.